Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Mallela, T."'
Autor:
Rose L; The Ohio State University College of Medicine, Columbus, OH, USA., Mallela T; The Ohio State University College of Medicine, Columbus, OH, USA., Waters M; The Ohio State University College of Medicine, Columbus, OH, USA., Novice M; The University of Michigan Medical School, Ann Arbor, MI, USA., Minta A; The Ohio State University College of Medicine, Columbus, OH, USA., Akintilo L; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York City, NY, USA., Shipp D; Department of Dermatology, The Ohio State University Wexner Medical Center, 540 Officenter Place, Suite 240, Columbus, OH, 43230, USA., Dulmage B; Department of Dermatology, The Ohio State University Wexner Medical Center, 540 Officenter Place, Suite 240, Columbus, OH, 43230, USA. Brittany.Dulmage@osumc.edu.
Publikováno v:
Archives of dermatological research [Arch Dermatol Res] 2024 May 24; Vol. 316 (6), pp. 223. Date of Electronic Publication: 2024 May 24.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Journal of Investigative Dermatology August 2024 144(8) Supplement:S22-S22
Autor:
Gallardo MA; College of Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio., Mallela T; College of Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio., Gilkey T; College of Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio., Himed S; College of Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio; University of Cincinnati College of Medicine, Cincinnati, Ohio., Walker TD; College of Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio., Nusbaum KB; University of Cincinnati College of Medicine, Cincinnati, Ohio., Korman A; Department of Dermatology, Ohio State University Wexner Medical Center, Columbus, Ohio., Trinidad J; Department of Dermatology, Ohio State University Wexner Medical Center, Columbus, Ohio., Chung C; Department of Dermatology, Ohio State University Wexner Medical Center, Columbus, Ohio; Department of Pathology, Ohio State University Wexner Medical Center, Columbus, Ohio., Kaffenberger BH; Department of Dermatology, Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: Benjamin.Kaffenberger@osumc.edu.
Publikováno v:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 May; Vol. 88 (5), pp. 1142-1145. Date of Electronic Publication: 2022 Nov 25.
Autor:
Mital R; Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USA. rohan.mital@osumc.edu.; College of Medicine, The Ohio State University, Columbus, OH, USA. rohan.mital@osumc.edu., Gray A; Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; College of Medicine, The Ohio State University, Columbus, OH, USA., Minta A; Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; College of Medicine, The Ohio State University, Columbus, OH, USA., Almhana F; College of Medicine, The Ohio State University, Columbus, OH, USA., Amin S; College of Medicine, The Ohio State University, Columbus, OH, USA., Hydol-Smith J; School of Medicine, Texas A&M University, College Station, TX, USA., Mallela T; College of Medicine, The Ohio State University, Columbus, OH, USA., Kaffenberger BH; Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2023 Jan; Vol. 13 (1), pp. 77-94. Date of Electronic Publication: 2022 Nov 25.
Autor:
Gabriela Gómez-Martínez, Lina1 linaggm@gmail.com, Arenas-Aya, Dayana2, Morales-Naranjo, Samuel3, Montoya-Agudelo, Fernando4
Publikováno v:
Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica. abr-jun2024, Vol. 32 Issue 2, p193-202. 10p.
Autor:
Yuan, Jiali1 (AUTHOR), Mo, Yiqun1 (AUTHOR), Zhang, Yuanbao1 (AUTHOR), Zhang, Yue1 (AUTHOR), Zhang, Qunwei1 (AUTHOR) Qunwei.Zhang@louisville.edu
Publikováno v:
Nanotoxicology. Aug-Oct2022, Vol. 16 Issue 6-8, p695-712. 18p.
Autor:
Tetart F; Department of Dermatology and Allergology, Charles Nicolle University Hospital, Rouen, France.; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France., Walsh S; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, King's College Hospital, London, UK., Milpied B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France., Gaspar K; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Vorobyev A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.; Department of Dermatology, University Medical Center Schleswig-Holstein, Lübeck, Germany., Tiplica GS; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology II, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Didona B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Center of Rare Diseases IDI-IRCCS-Rome, Rome, Italy., Welfringer-Morin A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Necker-Enfants Malades University Hospital, Paris, France., Kucinskiene V; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Skin and Venereal Diseases, Lithuanian University of Health Sciences (LUHS), Hospital of LUHS Kauno Klinikos, Kaunas, Lithuania., Bensaid B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, Edouard Herriot University Hospital, Lyon, France., Marvanova E; Department of Dermatovenereology, Faculty of Medicine, St. Ann's University Hospital, Masaryk University, Brno, Czech Republic., Salavastru C; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Paediatric Dermatology, Colentina University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Brezinova E; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatovenereology, Faculty of Medicine, St. Ann's University Hospital, Masaryk University, Brno, Czech Republic., Chua SL; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, University Hospitals Birmingham, Birmingham, UK., Lovgren ML; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Birmingham Children's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK., Hammers CM; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Christian-Albrechts-University Kiel, Kiel, Germany., Barbaud A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology and Allergology, Tenon Hospital, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Paris, France., Mortz CG; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark., Horvath B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, Center for Blistering Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Meyersburg D; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology and Allergology, University Hospital Salzburg of the Paracelsus Medical University Salzburg, Salzburg, Austria., Lebrun-Vignes B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Regional Pharmacovigilance Centre, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France., Bodemer C; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, Necker-Enfants Malades University Hospital, Paris, France., Brüggen MC; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Christine Kühne-Center for Allergy Research and Education Davos (CK-CARE), Davos, Switzerland., French LE; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.; Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA., Ingen-Housz-Oro S; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France.; Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, AP-HP, Henri Mondor University Hospital, Créteil, France.; Univ Paris Est Créteil EpiDermE, Créteil, France.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Jul 18. Date of Electronic Publication: 2024 Jul 18.
Autor:
PR Newswire
Publikováno v:
PR Newswire US. 05/16/2023.